Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Acadia Pharmaceuticals buy Royal Bank of Canada

Acadia Pharmaceuticals
Start price
€14.79
25.06.24 / 50%
Target price
€27.09
25.06.25
Performance (%)
3.41%
Price
€15.30
27.06.24
Summary
This prediction is currently active. With a performance of 3.41%, the BUY prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals is trending in the right direction. This prediction currently runs until 25.06.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w
Acadia Pharmaceuticals 3.41%
iShares Core DAX® 0.238%
iShares Nasdaq 100 -0.304%
iShares Nikkei 225® 2.271%
iShares S&P 500 -0.296%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 3.41%
Target price 27.095
Change
Ends at 25.06.25

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $29.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat

Royal Bank of Canada 
0
Report Share
25.06.24

Stopped prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€22.00
28.02.24
€32.29
28.02.25
-30.48%
27.06.24

Royal Bank of Canada 
28.02.24 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€22.60
03.11.23
€30.73
03.11.24
-32.32%
27.06.24

Royal Bank of Canada 
03.11.23 50%
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€29.00
14.07.23
€29.37
14.07.24
-47.26%
27.06.24

Royal Bank of Canada 
14.07.23 50%